Oriola
1,094
EUR
-0,73 %
7.716 følger denne virksomhed
ORIOLA
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Investor consensus
-0,73%
+0,18%
+10,95%
+22,92%
+24,89%
+14,68%
-46,63%
-47,9%
-40,52%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Læs mereMarkedsværdi
202,75 mio. EUR
Aktieomsætning
72,33 t EUR
P/E (adj.) (25e)
18,09
EV/EBIT (adj.) (25e)
4,84
P/B (25e)
1,69
EV/S (25e)
0,06
Udbytteafkast, % (25e)
6,4 %
Omsætning og EBIT-margin
Omsætning mia.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
18.7
2025
Delårsrapport Q2'25
30.10
2025
Delårsrapport Q3'25
Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Oriola Oyj: Oriola Corporation - Managers' transactions - Närhinen
Oriola Oyj: Oriola Corporation - Managers' transactions - Mähönen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Oriola Oyj: Oriola Corporation - Managers' transactions - Axdorff
Oriola Oyj: Oriola Corporation - Managers' transactions - Carlsson Meyer
Oriola Oyj: Oriola Corporation - Managers' transactions - Westerlund
Oriola Oyj: Oriola Corporation - Managers' transactions - Persdotter Nilsson
Oriola Oyj: Oriola Corporation - Managers' transactions - Pärssinen

Oriola Q1’25: Unusual volume fluctuation
